2,4-dihydroxyfuro[3,4-d]pyriMidin-7(5H)-one

2,4-dihydroxyfuro[3,4-d]pyriMidin-7(5H)-one Suppliers list
Company Name: Adamas Reagent, Ltd.  
Tel: 400-6009262 15618770481
Email: yhx@titansci.com
Company Name: Shanghai Boyners Pharm-Tech Co., Ltd.  
Tel: 13817873692
Email: mkt@boynerspharm.com
Company Name: Shanghai TuZhi Chemical Co., Ltd.  
Tel: 19542790274
Email: 2119559397@qq.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Amadis Chemical Company Limited  
Tel: 571-89925085
Email: sales@amadischem.com
2,4-dihydroxyfuro[3,4-d]pyriMidin-7(5H)-one Basic information
Product Name:2,4-dihydroxyfuro[3,4-d]pyriMidin-7(5H)-one
Synonyms:2,4-dihydroxyfuro[3,4-d]pyriMidin-7(5H)-one;2,4-Dichlorofuro[3,4-d]pyrimidin-7(5H)-one;2,4-dichloro-5H-furo[3,4-d]pyrimidin-7-one;Furo[3,4-d]pyrimidin-7(5H)-one, 2,4-dichloro-
CAS:15783-48-9
MF:C6H2Cl2N2O2
MW:205
EINECS:810-328-3
Product Categories:
Mol File:15783-48-9.mol
2,4-dihydroxyfuro[3,4-d]pyriMidin-7(5H)-one Structure
2,4-dihydroxyfuro[3,4-d]pyriMidin-7(5H)-one Chemical Properties
Boiling point 464.0±45.0 °C(Predicted)
density 1.760±0.06 g/cm3(Predicted)
storage temp. under inert gas (nitrogen or Argon) at 2-8°C
pka-5.44±0.20(Predicted)
AppearanceOff-white to yellow Solid
Safety Information
MSDS Information
2,4-dihydroxyfuro[3,4-d]pyriMidin-7(5H)-one Usage And Synthesis
Synthesis
LACTONE 5-HYDROXYMETHYL OROTIC ACID

4156-75-6

2,4-dihydroxyfuro[3,4-d]pyriMidin-7(5H)-one

15783-48-9

Step 2-Synthesis of 2,4-dichlorofuro[3,4-d]pyrimidin-7(5H)-one (fq): to a suspension of 5-hydroxymethyl orotate lactone (fp) (550 mg, 3.3 mmol) in dichloromethane (2.5 mL) was added drop-wise triethylamine (TEA) (0.91 mL, 6.5 mmol), followed by phosphorus oxychloride (POCl3) ( 4.5 mL, 48 mmol). The reaction mixture was stirred at 90 °C overnight. Upon completion of the reaction, the solvent was removed by distillation under reduced pressure. The residue was carefully poured into ice water and extracted with dichloromethane (3×). The organic phases were combined, dried over anhydrous magnesium sulfate (MgSO4), filtered and concentrated under reduced pressure to give 510 mg (76% yield) of the target product (fq) as a brown solid. The product could be used in subsequent reactions without further purification; LC-MS: m/z = 205 ([M+H]+).

References[1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 7, p. 2565 - 2571
[2] Patent: US2010/331305, 2010, A1. Location in patent: Page/Page column 75
[3] Patent: US2011/21515, 2011, A1. Location in patent: Page/Page column 10
[4] Patent: WO2012/99581, 2012, A1. Location in patent: Page/Page column 21
2,4-dihydroxyfuro[3,4-d]pyriMidin-7(5H)-one Preparation Products And Raw materials
Raw materialsLactone 5-hydroxymethyl orotic acid-->trichlorophosphate-->Dichloromethane-->Triethylamine
Tag:2,4-dihydroxyfuro[3,4-d]pyriMidin-7(5H)-one(15783-48-9) Related Product Information
2,4-Dichloro-5,7-dihydrofuro[3,4-d]pyrimidine 2,4-Dichloro-7-Methyl-5,7-dihydrofuro[3,4-d]pyriMidine 2,4-Dichloro-7,7-diMethyl-5,7-dihydrofuro[3,4-d]pyriMidine Ethyl 6-chloro-5-methylpyrimidine-4-carboxylate 4-Pyrimidinecarboxylic acid, 2,6-dichloro-5-methyl-, methyl ester Furo[3,4-d]pyrimidine, 2,4-dichloro-5,7-dihydro-7-methyl-, (7S)-